Teladoc Health Announces Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Teladoc (TDOC) Tops Q3 EPS by 2c, Revenues Beat; Offers FY18 Revenue Outlook Above Consensus, FY18 EPS View In-Line with Estimates
November 1, 2018 4:35 PM EDTTeladoc (NYSE: TDOC) reported Q3 EPS of ($0.34), $0.02 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $111 million versus the consensus estimate of $109.95 million.
Teladoc Health delivered very strong third quarter results. We carry significant momentum into the... More
